Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
GMED 
Globus Medical (GMED)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: GMED (3-star) is a STRONG-BUY. BUY since 55 days. Simulated Profits (51.52%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $105.7
1 Year Target Price $105.7
| 4 | Strong Buy |
| 5 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 70.21% | Avg. Invested days 48 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.78B USD | Price to earnings Ratio 30.62 | 1Y Target Price 105.7 |
Price to earnings Ratio 30.62 | 1Y Target Price 105.7 | ||
Volume (30-day avg) 14 | Beta 1.07 | 52 Weeks Range 51.79 - 101.40 | Updated Date 01/9/2026 |
52 Weeks Range 51.79 - 101.40 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.09 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 15.3% | Operating Margin (TTM) 22.21% |
Management Effectiveness
Return on Assets (TTM) 6.43% | Return on Equity (TTM) 10.01% |
Valuation
Trailing PE 30.62 | Forward PE 23.26 | Enterprise Value 12392681886 | Price to Sales(TTM) 4.61 |
Enterprise Value 12392681886 | Price to Sales(TTM) 4.61 | ||
Enterprise Value to Revenue 4.47 | Enterprise Value to EBITDA 17.46 | Shares Outstanding 111409069 | Shares Floating 110486908 |
Shares Outstanding 111409069 | Shares Floating 110486908 | ||
Percent Insiders 0.68 | Percent Institutions 108.63 |
Upturn AI SWOT
Globus Medical
Company Overview
History and Background
Globus Medical was founded in 2003 by David C. Pauker and Daniel J. Suggs with the mission to create technologies that help patients regain a life free from pain. The company is a leader in the musculoskeletal solutions market. Significant milestones include the development of innovative spinal implant technologies and the expansion into robotics and biologics.
Core Business Areas
- Musculoskeletal Solutions: Globus Medical designs, manufactures, and sells a comprehensive suite of products for the surgical treatment of musculoskeletal disorders. This includes implants, instruments, and biologics for spine, trauma, and general orthopedic procedures.
- Robotics: The company has a significant investment in robotics, particularly its ExcelsiusGPSu00ae robotic navigation platform, which integrates navigation, robotics, and advanced visualization to assist surgeons in creating reproducible surgical plans and improving patient outcomes.
- Oversight: Globus Medical offers a range of procedural solutions and educational programs to support healthcare providers in adopting their technologies.
Leadership and Structure
Globus Medical is led by its executive management team, with Daniel J. Suggs serving as President and CEO. The company is structured to support its core business segments, focusing on product development, sales, marketing, and clinical support.
Top Products and Market Share
Key Offerings
- ExcelsiusGPSu00ae Robotic Navigation Platform: A robotic system that combines navigation, robotics, and intraoperative imaging for spine and neurosurgery. Competitors include Medtronic (Mazor Robotics), Stryker (Mako Robotic-Arm Assisted Surgery), and Zimmer Biomet (ROSA Knee System).
- Spinal Implants: A broad portfolio of implants for spinal fusion, motion preservation, and deformity correction. Key competitors include Medtronic, Johnson & Johnson (DePaxo), and Stryker.
- Trauma and Extremities Products: Implants and instruments for treating fractures and other injuries in the extremities and axial skeleton. Competitors include Stryker, Zimmer Biomet, and Smith & Nephew.
- Biologics: Bone graft substitutes and other biological materials used to promote bone healing. Competitors include Medtronic and NuVasive.
Market Dynamics
Industry Overview
The musculoskeletal solutions market is a large and growing sector driven by an aging global population, increasing prevalence of degenerative diseases, and advancements in surgical techniques and technologies, including robotics and biologics. Competition is intense, with significant players focusing on innovation and market penetration.
Positioning
Globus Medical is positioned as an innovative leader in the musculoskeletal market, particularly strong in spinal solutions and with a growing presence in robotic surgery. Its integrated approach, combining implants, robotics, and biologics, offers a competitive advantage.
Total Addressable Market (TAM)
The global orthopedic device market is estimated to be over $50 billion and growing. Globus Medical's TAM encompasses spinal, trauma, and orthopedic surgical solutions, with a significant focus on the spine segment, which is a multi-billion dollar market. The company is well-positioned to capture a substantial share through its innovative product portfolio and strategic focus on technology.
Upturn SWOT Analysis
Strengths
- Strong product innovation, particularly in spinal implants and robotics.
- Integrated offerings of implants, biologics, and robotic technology.
- Experienced management team and strong sales force.
- Focus on improving patient outcomes and surgeon efficiency.
Weaknesses
- Relatively smaller market share compared to larger, more diversified medical device companies.
- Dependence on key product lines.
- High R&D investment requirements for continuous innovation.
Opportunities
- Expansion into new geographic markets.
- Further development and adoption of robotic surgery platforms.
- Growth in biologics and regenerative medicine.
- Strategic acquisitions to expand product portfolio or market reach.
Threats
- Intense competition and pricing pressures.
- Regulatory hurdles and changes in healthcare policy.
- Economic downturns impacting healthcare spending.
- Technological disruptions from competitors.
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Johnson & Johnson (JNJ)
- Stryker Corporation (SYK)
- Zimmer Biomet Holdings (ZBH)
- NuVasive (NUVA)
Competitive Landscape
Globus Medical competes in a highly consolidated market dominated by larger players like Medtronic and Johnson & Johnson. Its competitive advantages lie in its technological innovation, particularly in robotics and integrated solutions, and its focus on the musculoskeletal space. However, it faces challenges in matching the scale, global reach, and diversified product portfolios of its larger rivals.
Major Acquisitions
Effectus Solutions
- Year: 2022
- Acquisition Price (USD millions): 300
- Strategic Rationale: To enhance its biologics portfolio and expand its offerings in bone graft substitutes.
Outpatient Solutions
- Year: 2021
- Acquisition Price (USD millions): 150
- Strategic Rationale: To strengthen its position in outpatient surgical solutions and expand its reach into ambulatory surgery centers.
Growth Trajectory and Initiatives
Historical Growth: Globus Medical has exhibited consistent historical revenue growth, driven by its innovative product pipeline, particularly in the spine segment, and the increasing adoption of its robotic platforms. This growth has been fueled by both organic expansion and strategic product introductions.
Future Projections: Analyst estimates typically project continued revenue growth for Globus Medical, driven by the expanding musculoskeletal market, the growing adoption of robotic surgery, and the company's ongoing product development efforts. Projections will vary based on the specific analyst and timeframe.
Recent Initiatives: Recent initiatives likely include the continued development and commercialization of its ExcelsiusGPSu00ae robotic system, expansion of its biologics portfolio, and potential new product launches in spine and trauma. The company may also be exploring strategic partnerships or acquisitions.
Summary
Globus Medical is a strong player in the musculoskeletal solutions market, distinguished by its innovative robotic technology and integrated product offerings. Its consistent revenue growth and strategic focus on improving patient outcomes are key strengths. However, it faces intense competition from larger, established players and must continue to invest heavily in R&D to maintain its competitive edge and expand its market share globally.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations (Annual and Quarterly Reports)
- Financial News Outlets (e.g., Bloomberg, Wall Street Journal)
- Industry Research Reports
- Company Press Releases
Disclaimers:
This information is for informational purposes only and should not be construed as financial advice. Market share data is an estimation and may vary across different reports. Financial data should be verified with the latest official filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Globus Medical
Exchange NYSE | Headquaters Audubon, PA, United States | ||
IPO Launch date 2012-08-03 | CEO, President & Director Mr. Keith W. Pfeil | ||
Sector Healthcare | Industry Medical Devices | Full time employees 5300 | Website https://www.globusmedical.com |
Full time employees 5300 | Website https://www.globusmedical.com | ||
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.